Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
The Astellas Life Sciences Center hosts the company's first U.S.-based open innovation SakuLab™ incubator space dedicated to fostering pioneering science through collaboration with external partners
- Collaboration to focus on gene therapy research for the treatment of ultra-rare disease NORTHBROOK, Ill., June 20, 2024 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") announced today the...
Read more about Astellas Announces Sponsored Research Agreement with UMass Chan Medical School
Community-driven collaboration aims to raise awareness of the value PAOs offer patients and their caregivers NORTHBROOK, Ill., June 10, 2024 /PRNewswire/ -- Astellas is proud to announce that it...
- 154,000 square-foot lab and office facility creates a central location for Astellas' West Coast cell and gene therapy research and business development operations TOKYO and SAN FRANCISCO, May 8,...
Permanent J-code J2782 effective April 1, 2024 NORTHBROOK, Ill., March 26, 2024 /PRNewswire/ -- Iveric Bio, An Astellas Company (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), today...
Follow U.S. news
